BD MAX MRSA XT, BD MAX INSTRUMENT

System, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen

GENEOHM SCIENCES CANADA, INC.

The following data is part of a premarket notification filed by Geneohm Sciences Canada, Inc. with the FDA for Bd Max Mrsa Xt, Bd Max Instrument.

Pre-market Notification Details

Device IDK133605
510k NumberK133605
Device Name:BD MAX MRSA XT, BD MAX INSTRUMENT
ClassificationSystem, Nucleic Acid Amplification Test, Dna, Methicillin Resistant Staphylococcus Aureus, Direct Specimen
Applicant GENEOHM SCIENCES CANADA, INC. 2555 BOUL. DU PARC-TECHNOLOGIQUE Quebec,  CA G19 4s5
ContactPatricia Dionne
CorrespondentPatricia Dionne
GENEOHM SCIENCES CANADA, INC. 2555 BOUL. DU PARC-TECHNOLOGIQUE Quebec,  CA G19 4s5
Product CodeNQX  
CFR Regulation Number866.1640 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2013-11-25
Decision Date2013-12-20
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00382904434618 K133605 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.